INDOLENT B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for INDOLENT B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new INDOLENT B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for INDOLENT B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR T-Cell therapy aims to tackle tough lymphoma
Disease control Recruiting nowThis early-stage study tests a new treatment called SynKIR-310 for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment uses a patient's own immune cells, modified to better recognize and attack cancer cells. T…
Matched conditions: INDOLENT B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Could fewer zaps of radiation work just as well for lymphoma?
Disease control Recruiting nowThis study compares a reduced dose of radiation (3 treatments) against the standard 12 treatments for people with indolent non-Hodgkin lymphoma, a slow-growing blood cancer. The goal is to see if the shorter course is safer and still controls the disease. About 112 adults with ce…
Matched conditions: INDOLENT B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 15, 2026 11:56 UTC